Buckingham Capital Management (Ohio)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,891
Closed -$1.17M 130
2018
Q4
$1.17M Sell
3,891
-32
-0.8% -$10.2K 0.26% 79
2018
Q3
$1.39M Buy
3,923
+27
+0.7% +$9.3K 0.27% 81
2018
Q2
$1.13M Sell
3,896
-30
-0.8% -$8.43K 0.23% 89
2018
Q1
$1.07M Buy
3,926
+853
+28% +$265K 0.23% 93
2017
Q4
$979K Buy
3,073
+350
+13% +$112K 0.21% 101
2017
Q3
$853K Buy
2,723
+318
+13% +$94.2K 0.19% 105
2017
Q2
$653K Sell
2,405
-47
-2% -$12.4K 0.15% 116
2017
Q1
$670K Buy
2,452
+8
+0.3% +$2.26K 0.16% 117
2016
Q4
$693K Sell
2,444
-434
-15% -$129K 0.17% 115
2016
Q3
$901K Buy
2,878
+126
+5% +$37.3K 0.23% 104
2016
Q2
$665K Buy
2,752
+55
+2% +$14.5K 0.18% 121
2016
Q1
$702K Buy
2,697
+209
+8% +$55.2K 0.19% 116
2015
Q4
$762K Buy
2,488
+196
+9% +$56.3K 0.21% 112
2015
Q3
$669K Buy
2,292
+1,077
+89% +$356K 0.2% 120
2015
Q2
$492K Buy
1,215
+558
+85% +$224K 0.14% 136
2015
Q1
$277K Buy
+657
New +$259K 0.08% 166

Other funds holding BIIB

Buckingham Capital Management (Ohio)'s BIIB Position: Q1 2019 in Review

Buckingham Capital Management (Ohio) sold out of Biogen (BIIB) in Q1 2019, closing a stake of 3,891 shares — an estimated $1.17M sold.

Buckingham Capital Management (Ohio) first reported a position in BIIB in Q1 2015 and held it in 16 quarters. The position peaked at $1.39M in Q3 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Buckingham Capital Management (Ohio) reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Buckingham Capital Management (Ohio) sold 3,891 Biogen shares in Q1 2019, an estimated $1.17M.
  • Buckingham Capital Management (Ohio) first reported a position in Biogen in Q1 2015 and held it in 16 quarters.
  • Buckingham Capital Management (Ohio)'s Biogen position peaked at $1.39M in Q3 2018.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Buckingham Capital Management (Ohio)'s 13F filing for Q1 2019, filed 7 May 2019.